As the global economy mends, the 2021 growth of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) will have significant change from previous year. According to our (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size is USD million in 2022 from USD 14070 million in 2021, with a change of % between 2021 and 2022. The global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size will reach USD 57240 million in 2028, growing at a CAGR of 22.2% over the analysis period.
The United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market, reaching US$ million by the year 2028. As for the Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) players cover Janssen, Qiagen, Advanced Cell Diagnostics, and ApoCell, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
- CellSearch
- Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
- Breast Cancer Diagnosis and Treatment
- Prostate Cancer Diagnosis and Treatment
- Colorectal Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Other Cancers Diagnosis and Treatment
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
- Janssen
- Qiagen
- Advanced Cell Diagnostics
- ApoCell
- Biofluidica
- Clearbridge Biomedics
- CytoTrack
- Celsee
- Fluxion
- Gilupi
- Cynvenio
- On-chip
- YZY Bio
- BioView
- Fluidigm
- Ikonisys
- AdnaGen
- IVDiagnostics
- Miltenyi Biotec
- ScreenCell
- Silicon Biosystems
Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2022-2028
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2017-2028
2.1.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Segment by Type
2.2.1 CellSearch
2.2.2 Others
2.3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type
2.3.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type (2017-2022)
2.4 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Segment by Application
2.4.1 Breast Cancer Diagnosis and Treatment
2.4.2 Prostate Cancer Diagnosis and Treatment
2.4.3 Colorectal Cancer Diagnosis and Treatment
2.4.4 Lung Cancer Diagnosis and Treatment
2.4.5 Other Cancers Diagnosis and Treatment
2.5 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application
2.5.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application (2017-2022)
3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Player
3.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Players
3.1.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Players (2020-2022)
3.1.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Players (2020-2022)
3.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Regions
4.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Regions (2017-2022)
4.2 Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth (2017-2022)
4.3 APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth (2017-2022)
4.4 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth (2017-2022)
4.5 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth (2017-2022)
5 Americas
5.1 Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2017-2022)
5.2 Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2017-2022)
5.3 Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Region (2017-2022)
6.2 APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2017-2022)
6.3 APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Country (2017-2022)
7.2 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2017-2022)
7.3 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Region (2017-2022)
8.2 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2017-2022)
8.3 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast
10.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecast by Regions (2023-2028)
10.1.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecast by Regions (2023-2028)
10.1.2 Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecast
10.1.3 APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecast
10.1.4 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecast
10.1.5 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecast
10.2 Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecast by Country (2023-2028)
10.2.1 United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast
10.2.2 Canada Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast
10.2.3 Mexico Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast
10.2.4 Brazil Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast
10.3 APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecast by Region (2023-2028)
10.3.1 China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast
10.3.2 Japan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast
10.3.3 Korea Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast
10.3.4 Southeast Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast
10.3.5 India Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast
10.3.6 Australia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast
10.4 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecast by Country (2023-2028)
10.4.1 Germany Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast
10.4.2 France Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast
10.4.3 UK Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast
10.4.4 Italy Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast
10.4.5 Russia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast
10.5 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecast by Region (2023-2028)
10.5.1 Egypt Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast
10.5.2 South Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast
10.5.3 Israel Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast
10.5.4 Turkey Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast
10.5.5 GCC Countries Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast
10.6 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecast by Type (2023-2028)
10.7 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Janssen
11.1.1 Janssen Company Information
11.1.2 Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.1.3 Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Janssen Main Business Overview
11.1.5 Janssen Latest Developments
11.2 Qiagen
11.2.1 Qiagen Company Information
11.2.2 Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.2.3 Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Qiagen Main Business Overview
11.2.5 Qiagen Latest Developments
11.3 Advanced Cell Diagnostics
11.3.1 Advanced Cell Diagnostics Company Information
11.3.2 Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.3.3 Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Advanced Cell Diagnostics Main Business Overview
11.3.5 Advanced Cell Diagnostics Latest Developments
11.4 ApoCell
11.4.1 ApoCell Company Information
11.4.2 ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.4.3 ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 ApoCell Main Business Overview
11.4.5 ApoCell Latest Developments
11.5 Biofluidica
11.5.1 Biofluidica Company Information
11.5.2 Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.5.3 Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Biofluidica Main Business Overview
11.5.5 Biofluidica Latest Developments
11.6 Clearbridge Biomedics
11.6.1 Clearbridge Biomedics Company Information
11.6.2 Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.6.3 Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Clearbridge Biomedics Main Business Overview
11.6.5 Clearbridge Biomedics Latest Developments
11.7 CytoTrack
11.7.1 CytoTrack Company Information
11.7.2 CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.7.3 CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 CytoTrack Main Business Overview
11.7.5 CytoTrack Latest Developments
11.8 Celsee
11.8.1 Celsee Company Information
11.8.2 Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.8.3 Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Celsee Main Business Overview
11.8.5 Celsee Latest Developments
11.9 Fluxion
11.9.1 Fluxion Company Information
11.9.2 Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.9.3 Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Fluxion Main Business Overview
11.9.5 Fluxion Latest Developments
11.10 Gilupi
11.10.1 Gilupi Company Information
11.10.2 Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.10.3 Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Gilupi Main Business Overview
11.10.5 Gilupi Latest Developments
11. Cynvenio
11.11.1 Cynvenio Company Information
11.11.2 Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.11.3 Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Cynvenio Main Business Overview
11.11.5 Cynvenio Latest Developments
11.12 On-chip
11.12.1 On-chip Company Information
11.12.2 On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.12.3 On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 On-chip Main Business Overview
11.12.5 On-chip Latest Developments
11.13 YZY Bio
11.13.1 YZY Bio Company Information
11.13.2 YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.13.3 YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 YZY Bio Main Business Overview
11.13.5 YZY Bio Latest Developments
11.14 BioView
11.14.1 BioView Company Information
11.14.2 BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.14.3 BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 BioView Main Business Overview
11.14.5 BioView Latest Developments
11.15 Fluidigm
11.15.1 Fluidigm Company Information
11.15.2 Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.15.3 Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Fluidigm Main Business Overview
11.15.5 Fluidigm Latest Developments
11.16 Ikonisys
11.16.1 Ikonisys Company Information
11.16.2 Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.16.3 Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Ikonisys Main Business Overview
11.16.5 Ikonisys Latest Developments
11.17 AdnaGen
11.17.1 AdnaGen Company Information
11.17.2 AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.17.3 AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 AdnaGen Main Business Overview
11.17.5 AdnaGen Latest Developments
11.18 IVDiagnostics
11.18.1 IVDiagnostics Company Information
11.18.2 IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.18.3 IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 IVDiagnostics Main Business Overview
11.18.5 IVDiagnostics Latest Developments
11.19 Miltenyi Biotec
11.19.1 Miltenyi Biotec Company Information
11.19.2 Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.19.3 Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Miltenyi Biotec Main Business Overview
11.19.5 Miltenyi Biotec Latest Developments
11.20 ScreenCell
11.20.1 ScreenCell Company Information
11.20.2 ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.20.3 ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 ScreenCell Main Business Overview
11.20.5 ScreenCell Latest Developments
11.21 Silicon Biosystems
11.21.1 Silicon Biosystems Company Information
11.21.2 Silicon Biosystems Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
11.21.3 Silicon Biosystems Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Silicon Biosystems Main Business Overview
11.21.5 Silicon Biosystems Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of CellSearch
Table 3. Major Players of Others
Table 4. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type (2017-2022)
Table 7. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application (2017-2022)
Table 10. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Player (2020-2022)
Table 12. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Key Players Head office and Products Offered
Table 13. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Regions (2017-2022)
Table 18. Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Country (2017-2022)
Table 20. Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type (2017-2022)
Table 22. Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application (2017-2022)
Table 24. APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Region (2017-2022)
Table 26. APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type (2017-2022)
Table 28. APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application (2017-2022)
Table 30. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Country (2017-2022)
Table 32. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type (2017-2022)
Table 34. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Table 43. Key Market Challenges & Risks of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Table 44. Key Industry Trends of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Table 45. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share Forecast by Application (2023-2028)
Table 51. Janssen Details, Company Type, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Area Served and Its Competitors
Table 52. Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 53. Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Janssen Main Business
Table 55. Janssen Latest Developments
Table 56. Qiagen Details, Company Type, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Area Served and Its Competitors
Table 57. Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 58. Qiagen Main Business
Table 59. Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Qiagen Latest Developments
Table 61. Advanced Cell Diagnostics Details, Company Type, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Area Served and Its Competitors
Table 62. Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 63. Advanced Cell Diagnostics Main Business
Table 64. Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Advanced Cell Diagnostics Latest Developments
Table 66. ApoCell Details, Company Type, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Area Served and Its Competitors
Table 67. ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 68. ApoCell Main Business
Table 69. ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. ApoCell Latest Developments
Table 71. Biofluidica Details, Company Type, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Area Served and Its Competitors
Table 72. Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 73. Biofluidica Main Business
Table 74. Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Biofluidica Latest Developments
Table 76. Clearbridge Biomedics Details, Company Type, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Area Served and Its Competitors
Table 77. Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 78. Clearbridge Biomedics Main Business
Table 79. Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Clearbridge Biomedics Latest Developments
Table 81. CytoTrack Details, Company Type, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Area Served and Its Competitors
Table 82. CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 83. CytoTrack Main Business
Table 84. CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. CytoTrack Latest Developments
Table 86. Celsee Details, Company Type, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Area Served and Its Competitors
Table 87. Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 88. Celsee Main Business
Table 89. Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Celsee Latest Developments
Table 91. Fluxion Details, Company Type, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Area Served and Its Competitors
Table 92. Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 93. Fluxion Main Business
Table 94. Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Fluxion Latest Developments
Table 96. Gilupi Details, Company Type, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Area Served and Its Competitors
Table 97. Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 98. Gilupi Main Business
Table 99. Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Gilupi Latest Developments
Table 101. Cynvenio Details, Company Type, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Area Served and Its Competitors
Table 102. Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 103. Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Cynvenio Main Business
Table 105. Cynvenio Latest Developments
Table 106. On-chip Details, Company Type, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Area Served and Its Competitors
Table 107. On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 108. On-chip Main Business
Table 109. On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. On-chip Latest Developments
Table 111. YZY Bio Details, Company Type, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Area Served and Its Competitors
Table 112. YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 113. YZY Bio Main Business
Table 114. YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. YZY Bio Latest Developments
Table 116. BioView Details, Company Type, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Area Served and Its Competitors
Table 117. BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 118. BioView Main Business
Table 119. BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. BioView Latest Developments
Table 121. Fluidigm Details, Company Type, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Area Served and Its Competitors
Table 122. Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 123. Fluidigm Main Business
Table 124. Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. Fluidigm Latest Developments
Table 126. Ikonisys Details, Company Type, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Area Served and Its Competitors
Table 127. Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 128. Ikonisys Main Business
Table 129. Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 130. Ikonisys Latest Developments
Table 131. AdnaGen Details, Company Type, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Area Served and Its Competitors
Table 132. AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 133. AdnaGen Main Business
Table 134. AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 135. AdnaGen Latest Developments
Table 136. IVDiagnostics Details, Company Type, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Area Served and Its Competitors
Table 137. IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 138. IVDiagnostics Main Business
Table 139. IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 140. IVDiagnostics Latest Developments
Table 141. Miltenyi Biotec Details, Company Type, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Area Served and Its Competitors
Table 142. Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 143. Miltenyi Biotec Main Business
Table 144. Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 145. Miltenyi Biotec Latest Developments
Table 146. ScreenCell Details, Company Type, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Area Served and Its Competitors
Table 147. ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
Table 148. ScreenCell Main
Global Cancer Immunomodulator Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 95
The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......
Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 158
According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period.
The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......
Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 131
According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period.
The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......
Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 125
According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period.
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......
Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024
Published: 27-Dec-2023 Price: US 3350 Onwards Pages: 112
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......
Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 26-Dec-2023 Price: US 3380 Onwards Pages: 101
Market Overview of Global Cancer Gene Therapy market:
According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......
T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024
Published: 25-Dec-2023 Price: US 3350 Onwards Pages: 85
CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively.
The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......
Global Kaposi Sarcoma Market Status and Outlook 2023-2028
Published: 22-Dec-2023 Price: US 3160 Onwards Pages: 107
Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......
Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 21-Dec-2023 Price: US 3380 Onwards Pages: 118
Market Overview of Global Cancer Immunomodulator market:
According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
